122 related articles for article (PubMed ID: 22024151)
1. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
4. The GIST paradigm: how to establish diagnostic and prognostic criteria.
Calabuig-Farinas S; Lopez-Guerrero JA; Llombart-Bosch A
Arkh Patol; 2011; 73(4):13-21. PubMed ID: 22164425
[TBL] [Abstract][Full Text] [Related]
5. Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.
Mitomi H; Fukui N; Kishimoto I; Tanabe S; Kikuchi S; Saito T; Hayashi T; Yao T
Hum Pathol; 2011 Oct; 42(10):1505-13. PubMed ID: 21496871
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16
Wang JL; Wu JH; Hong C; Wang YN; Zhou Y; Long ZW; Zhou Y; Qin HS
Pathol Res Pract; 2017 Dec; 213(12):1542-1551. PubMed ID: 29042141
[TBL] [Abstract][Full Text] [Related]
9. Role of p16/INK4a in gastrointestinal stromal tumor progression.
Ricci R; Arena V; Castri F; Martini M; Maggiano N; Murazio M; Pacelli F; Potenza AE; Vecchio FM; Larocca LM
Am J Clin Pathol; 2004 Jul; 122(1):35-43. PubMed ID: 15272528
[TBL] [Abstract][Full Text] [Related]
10. P16 overexpression in BRAF-mutated gastrointestinal stromal tumors.
Shi SS; Wang X; Xia QY; Rao Q; Shen Q; Ye SB; Li R; Shi QL; Lu ZF; Ma HH; Zhou XJ
Expert Rev Mol Diagn; 2017 Feb; 17(2):195-201. PubMed ID: 28034324
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of P16 gene methylation and P16 protein expression in gastrointestinal stromal tumor].
Liang JF; Zheng HX; Li N; Cheng CX; Xiao H; Wang HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):372-5. PubMed ID: 17659467
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
13. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
14. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.
Schneider-Stock R; Boltze C; Lasota J; Peters B; Corless CL; Ruemmele P; Terracciano L; Pross M; Insabato L; Di Vizio D; Iesalnieks I; Dirnhofer S; Hartmann A; Heinrich M; Miettinen M; Roessner A; Tornillo L
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):638-45. PubMed ID: 15701851
[TBL] [Abstract][Full Text] [Related]
15. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
19. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
20. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]